Video Testimony Proper In AndroGel Probe: DC Circ.

By Pete Brush

Law360, New York (October 23, 2009, 7:00 PM ET) -- A district court was right to order three current or former executives to give videotaped testimony to the Federal Trade Commission in its probe into whether pharmaceutical companies unlawfully delayed entry into the market of a generic version of the testosterone supplement AndroGel, a federal appeals court has ruled.

Friday's ruling in the U.S. Court of Appeals for the District of Columbia Circuit said the trio's objections to the June 2008 ruling in the U.S. District Court for the District of Columbia were "utterly without merit."...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles